Insider Trading activities of Five Prime Therapeutics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Five Prime Therapeutics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Five Prime Therapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Five Prime Therapeutics Inc since 2005. The reporting company's ticker symbol is FPRX. The reporting company's CIK number is 1175505.
The total value of stock buying since 2005 is $2,535,615.
The total value of stock sales since 2005 is $26,954,787.
The total value of stock option exercises since 2005 is $4,505,101.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Five Prime Therapeutics Inc (FPRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 600 $24,468 11,651 $94,016
2017-09 0 $0 3,200 $124,000 3,200 $37,280
2017-06 0 $0 0 $0 8,280 $45,871
2017-03 0 $0 500 $23,365 500 $5,825
2017-02 0 $0 500 $23,085 500 $5,825
2017-01 0 $0 4,136 $197,845 4,136 $25,968
2016-12 0 $0 30,500 $1,551,510 30,500 $196,925
2016-11 0 $0 44,994 $2,669,269 44,994 $291,792
2016-10 0 $0 500 $26,000 14,320 $26,729
2016-09 0 $0 500 $22,100 500 $5,825
2016-08 0 $0 500 $25,385 500 $5,825
2016-07 0 $0 12,195 $603,652 12,195 $103,535
2016-05 0 $0 0 $0 81,300 $99,999
2016-04 11,090 $533,838 160,518 $7,441,975 160,518 $1,397,377
2016-03 0 $0 70,394 $2,723,473 70,394 $468,681
2016-02 0 $0 71,229 $2,423,210 71,229 $324,804
2016-01 0 $0 30,000 $1,059,150 54,695 $469,033
2015-10 0 $0 197,352 $5,465,194 0 $0
2015-09 0 $0 2,648 $58,422 23,338 $241,769
2015-08 0 $0 0 $0 3,000 $16,620
2015-07 0 $0 0 $0 23,001 $164,264
2015-06 0 $0 75,000 $1,837,800 47,840 $376,079
2015-04 0 $0 0 $0 3,557 $19,705
2015-01 35,049 $938,707 0 $0 0 $0
2014-12 0 $0 0 $0 14,366 $81,354
2014-11 1,951 $41,045 20,702 $270,663 0 $0
2014-10 0 $0 29,298 $384,221 0 $0
2014-08 400 $4,300 0 $0 0 $0
2013-11 500 $5,050 0 $0 0 $0
2013-09 77,787 $1,012,675 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Five Prime Therapeutics Inc insiders (FPRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-12 Knickerbocker Aron Marc (Chief Operating Officer) Option Ex 11,051 7.88 87,026
2017-10-02 Ringo William R (Director) Sale 600 40.78 24,468
2017-10-02 Ringo William R (Director) Option Ex 600 11.65 6,990
2017-09-29 Ringo William R (Director) Sale 1,200 40.00 48,000
2017-09-29 Ringo William R (Director) Option Ex 1,200 11.65 13,980
2017-09-28 Ringo William R (Director) Sale 2,000 38.00 76,000
2017-09-28 Ringo William R (Director) Option Ex 2,000 11.65 23,300
2017-06-16 Knickerbocker Aron Marc (Chief Operating Officer) Option Ex 8,280 5.54 45,871
2017-03-01 Ringo William R (Director) Sale 500 46.73 23,365
2017-03-01 Ringo William R (Director) Option Ex 500 11.65 5,825
2017-02-01 Ringo William R (Director) Sale 500 46.17 23,085
2017-02-01 Ringo William R (Director) Option Ex 500 11.65 5,825
2017-01-18 Sarena Francis Willard (Chief Strategy Officer) Sale 3,636 47.39 172,310
2017-01-18 Sarena Francis Willard (Chief Strategy Officer) Option Ex 3,636 5.54 20,143
2017-01-03 Ringo William R (Director) Sale 500 51.07 25,535
2017-01-03 Ringo William R (Director) Option Ex 500 11.65 5,825
2016-12-23 Williams Lewis T (President, CEO and Chairman) Sale 30,000 50.76 1,522,650
2016-12-23 Williams Lewis T (President, CEO and Chairman) Option Ex 30,000 6.37 191,100
2016-12-01 Ringo William R (Director) Sale 500 57.72 28,860
2016-12-01 Ringo William R (Director) Option Ex 500 11.65 5,825
2016-11-28 Sarena Francis Willard (Chief Strategy Officer) Sale 1,710 60.14 102,839
2016-11-28 Sarena Francis Willard (Chief Strategy Officer) Option Ex 1,710 5.54 9,473
2016-11-25 Sarena Francis Willard (Chief Strategy Officer) Sale 21,189 60.48 1,281,510
2016-11-25 Sarena Francis Willard (Chief Strategy Officer) Option Ex 21,189 6.21 131,689
2016-11-23 Sarena Francis Willard (Chief Strategy Officer) Sale 13,465 60.23 810,996
2016-11-23 Sarena Francis Willard (Chief Strategy Officer) Option Ex 13,465 6.89 92,773
2016-11-09 Jensen Peder (Director) Sale 8,130 55.30 449,589
2016-11-09 Jensen Peder (Director) Option Ex 8,130 6.40 52,032
2016-11-01 Ringo William R (Director) Sale 500 48.67 24,335
2016-11-01 Ringo William R (Director) Option Ex 500 11.65 5,825
2016-10-12 Douglas R Lee (Director) Option Ex 1,219 1.23 1,499
2016-10-03 Mcdade Mark (Director) Option Ex 12,601 1.54 19,405
2016-10-03 Ringo William R (Director) Sale 500 52.00 26,000
2016-10-03 Ringo William R (Director) Option Ex 500 11.65 5,825
2016-09-01 Ringo William R (Director) Sale 500 44.20 22,100
2016-09-01 Ringo William R (Director) Option Ex 500 11.65 5,825
2016-08-01 Ringo William R (Director) Sale 500 50.77 25,385
2016-08-01 Ringo William R (Director) Option Ex 500 11.65 5,825
2016-07-27 Jensen Peder (Director) Sale 12,195 49.50 603,652
2016-07-27 Jensen Peder (Director) Option Ex 12,195 8.49 103,535
2016-05-06 Williams Lewis T (President, CEO and Chairman) Option Ex 81,300 1.23 99,999
2016-04-22 Belsky Marc (Senior Vice President and CFO) Sale 34,102 49.63 1,692,652
2016-04-22 Belsky Marc (Senior Vice President and CFO) Option Ex 34,102 10.80 368,233
2016-04-22 Berger Franklin M (Director) Buy 5,000 49.54 247,700
2016-04-21 Williams Lewis T (President, CEO and Chairman) Sale 48,121 48.05 2,312,214
2016-04-21 Williams Lewis T (President, CEO and Chairman) Option Ex 48,121 8.49 408,547
2016-04-20 Williams Lewis T (President, CEO and Chairman) Sale 550 48.00 26,400
2016-04-20 Williams Lewis T (President, CEO and Chairman) Option Ex 550 8.49 4,669
2016-04-19 Berger Franklin M (Director) Buy 6,090 46.98 286,138
2016-04-15 Williams Lewis T (President, CEO and Chairman) Sale 1,405 48.00 67,440
2016-04-15 Williams Lewis T (President, CEO and Chairman) Option Ex 1,405 8.49 11,928
2016-04-14 Williams Lewis T (President, CEO and Chairman) Sale 2,725 48.00 130,800
2016-04-14 Williams Lewis T (President, CEO and Chairman) Option Ex 2,725 8.49 23,135
2016-04-06 Williams Lewis T (President, CEO and Chairman) Sale 26,852 43.17 1,159,200
2016-04-06 Williams Lewis T (President, CEO and Chairman) Option Ex 26,852 8.49 227,973
2016-04-06 Belsky Marc (Senior Vice President and CFO) Sale 20,814 45.04 937,462
2016-04-06 Belsky Marc (Senior Vice President and CFO) Option Ex 20,814 6.37 132,585
2016-04-05 Williams Lewis T (President, CEO and Chairman) Sale 25,949 43.00 1,115,807
2016-04-05 Williams Lewis T (President, CEO and Chairman) Option Ex 25,949 8.49 220,307
2016-03-30 Williams Lewis T (President, CEO and Chairman) Sale 14,044 40.02 562,040
2016-03-30 Williams Lewis T (President, CEO and Chairman) Option Ex 14,044 6.89 96,763
2016-03-30 Sarena Francis Willard (EVP, Gen Counsel and Secretary) Sale 5,550 40.01 222,055
2016-03-30 Sarena Francis Willard (EVP, Gen Counsel and Secretary) Option Ex 5,550 8.49 47,119
2016-03-30 Belsky Marc (Senior Vice President and CFO) Sale 9,052 40.01 362,170
2016-03-30 Belsky Marc (Senior Vice President and CFO) Option Ex 9,052 4.56 41,277
2016-03-29 Williams Lewis T (President, CEO and Chairman) Sale 9,215 40.01 368,692
2016-03-29 Williams Lewis T (President, CEO and Chairman) Option Ex 9,215 6.89 63,491
2016-03-29 Sarena Francis Willard (EVP, Gen Counsel and Secretary) Sale 4,450 40.00 178,000
2016-03-29 Sarena Francis Willard (EVP, Gen Counsel and Secretary) Option Ex 4,450 8.49 37,780
2016-03-29 Belsky Marc (Senior Vice President and CFO) Sale 4,824 40.00 192,960
2016-03-29 Belsky Marc (Senior Vice President and CFO) Option Ex 4,824 4.56 21,997
2016-03-02 Williams Lewis T (President and CEO) Sale 23,259 36.01 837,556
2016-03-02 Williams Lewis T (President and CEO) Option Ex 23,259 6.89 160,254
2016-02-04 Williams Lewis T (President and CEO) Sale 71,229 34.02 2,423,210
2016-02-04 Williams Lewis T (President and CEO) Option Ex 71,229 4.56 324,804
2016-01-27 Sarena Francis Willard (EVP, Gen Counsel & Secretary) Sale 30,000 35.30 1,059,150
2016-01-27 Sarena Francis Willard (EVP, Gen Counsel & Secretary) Option Ex 30,000 8.64 259,200
2016-01-11 Cohen Fred E (Director) Option Ex 24,695 8.50 209,833
2015-10-15 Williams Lewis T (President and CEO) Sale 72,352 27.40 1,982,444
2015-10-15 Gross Phillip Sale 125,000 27.86 3,482,750
2015-09-25 Knickerbocker Aron Marc (EVP & Chief Business Officer) Option Ex 2,708 7.01 18,996
2015-09-22 Berger Franklin M (Director) Option Ex 12,500 12.70 158,750
2015-09-21 Williams Lewis T (President and CEO) Sale 2,648 22.06 58,422
2015-09-02 Berger Franklin M (Director) Option Ex 8,130 7.88 64,023
2015-08-11 Knickerbocker Aron Marc (SVP & Chief Business Officer) Option Ex 3,000 5.54 16,620
2015-07-29 Knickerbocker Aron Marc (SVP & Chief Business Officer) Option Ex 16,497 7.51 123,842
2015-07-01 Berger Franklin M (Director) Option Ex 6,504 6.21 40,422
2015-06-24 Knickerbocker Aron Marc (SVP & Chief Business Officer) Option Ex 38,084 8.11 308,861
2015-06-22 Williams Lewis T (President and CEO) Sale 75,000 24.50 1,837,800
2015-06-17 Berger Franklin M (Director) Option Ex 9,756 6.89 67,218
2015-04-10 Knickerbocker Aron Marc (SVP & Chief Business Officer) Option Ex 3,557 5.54 19,705
2015-01-28 Berger Franklin M (Director) Buy 25,000 27.03 675,750
2015-01-15 Berger Franklin M (Director) Buy 5,049 25.76 130,067
2015-01-14 Berger Franklin M (Director) Buy 5,000 26.58 132,890
2014-12-10 Knickerbocker Aron Marc (SVP & Chief Business Officer) Option Ex 14,366 5.66 81,354
2014-11-28 Berger Franklin M (Director) Buy 1,951 21.04 41,045
2014-11-04 Williams Lewis T (President and CEO) Sale 7,143 13.11 93,651
2014-11-03 Williams Lewis T (President and CEO) Sale 13,559 13.05 177,012
2014-10-31 Williams Lewis T (President and CEO) Sale 11,901 13.09 155,748
2014-10-30 Williams Lewis T (President and CEO) Sale 5,838 13.32 77,779
2014-10-29 Williams Lewis T (President and CEO) Sale 1,825 13.03 23,783
2014-10-28 Williams Lewis T (President and CEO) Sale 9,734 13.04 126,911
2014-08-22 Hambleton Julie (EVP & Chief Medical Officer) Buy 400 10.75 4,300
2013-11-06 Hambleton Julie (EVP & Chief Medical Officer) Buy 500 10.10 5,050
2013-09-30 Hambleton Julie (EVP & Chief Medical Officer) Buy 64 13.70 876
2013-09-23 Atwood Brian G (Director) Buy 76,923 13.00 999,999
2013-09-18 Hambleton Julie (EVP & Chief Medical Officer) Buy 800 14.75 11,800

Insider trading activities including stock purchases, stock sales, and option exercises of FPRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Five Prime Therapeutics Inc (symbol FPRX, CIK number 1175505) see the Securities and Exchange Commission (SEC) website.